Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Tissue engineering of tumor stromal microenvironment with application to cancer cell invasion.
[dystrophic epidermolysis bullosa]
3
D
organotypic
cultures
of
epithelial
cells
on
a
matrix
embedded
with
mesenchymal
cells
are
widely
used
to
study
epithelial
cell
differentiation
and
invasion
.
Rat
tail
type
I
collagen
and
/
or
matrix
derived
from
Engelbreth-
Holm
-
Swarm
mouse
sarcoma
cells
have
been
traditionally
employed
as
the
substrates
to
model
the
matrix
or
stromal
microenvironment
into
which
mesenchymal
cells
(
usually
fibroblasts
)
are
populated
.
Although
experiments
using
such
matrices
are
very
informative
,
it
can
be
argued
that
due
to
an
overriding
presence
of
a
single
protein
(
such
as
in
type
I
Collagen
)
or
a
high
content
of
basement
membrane
components
and
growth
factors
(
such
as
in
matrix
derived
from
mouse
sarcoma
cells
)
,
these
substrates
do
not
best
reflect
the
contribution
to
matrix
composition
made
by
the
stromal
cells
themselves
.
To
study
native
matrices
produced
by
primary
dermal
fibroblasts
isolated
from
patients
with
a
tumor
prone
,
genetic
blistering
disorder
(
recessive
dystrophic
epidermolysis
bullosa
)
,
we
have
adapted
an
existing
native
matrix
protocol
to
study
tumor
cell
invasion
.
Fibroblasts
are
induced
to
produce
their
own
matrix
over
a
prolonged
period
in
culture
.
This
native
matrix
is
then
detached
from
the
culture
dish
and
epithelial
cells
are
seeded
onto
it
before
the
entire
coculture
is
raised
to
the
air-liquid
interface
.
Cellular
differentiation
and
/
or
invasion
can
then
be
assessed
over
time
.
This
technique
provides
the
ability
to
assess
epithelial-mesenchymal
cell
interactions
in
a
3
D
setting
without
the
need
for
a
synthetic
or
foreign
matrix
with
the
only
disadvantage
being
the
prolonged
period
of
time
required
to
produce
the
native
matrix
.
Here
we
describe
the
application
of
this
technique
to
assess
the
ability
of
a
single
molecule
expressed
by
fibroblasts
,
type
VII
collagen
,
to
inhibit
tumor
cell
invasion
.
Diseases
Validation
Diseases presenting
"growth factors"
symptom
achondroplasia
alexander disease
aromatase deficiency
cholangiocarcinoma
dentin dysplasia
dentinogenesis imperfecta
dystrophic epidermolysis bullosa
kallmann syndrome
oligodontia
oral submucous fibrosis
primary effusion lymphoma
scrub typhus
severe combined immunodeficiency
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom